Global trade

Swiss president discusses tariffs with Pope Leo XIV

The President of the Confederation meets Pope Leo XIV

This content was published on Oct 3, 2025 Swiss president discusses tariffs and global affairs with Pope Leo XIV in the Vatican.

Global trade

UBS gaining support for compromise on Swiss capital rules

This content was published on Oct 3, 2025 Liberal and right-wing lawmakers and lobbyists are discussing proposal that could slash capital increase by $10 billion or more.

Karin Keller-Sutter discusses financial stability in Copenhagen

Foreign Affairs

Swiss president stresses economic cooperation at Copenhagen summit

This content was published on Oct 2, 2025 Swiss president Karin Keller-Sutter urges economic stability at Copenhagen summit.

Government circles: New US pharmaceutical tariffs to start later

Global trade

US delays pharma tariffs to push for more drug pricing deals

This content was published on Oct 2, 2025 US delays pharma tariffs, urging companies to relocate production or lower prices.

Pfizer's US deal gives Novartis and Roche wings on the stock exchange

Global trade

Pfizer deal gives Novartis and Roche stocks boost

This content was published on Oct 1, 2025 Pharma stocks rebound in the wake of Pfizer's US tariff deal.

Global trade

More than a third of Swiss companies report irregularities

This content was published on Oct 1, 2025 In 2024, more than one third of Swiss companies were affected by illegal and unethical behaviour within their organisation or in their supply chain. Swiss companies are therefore less affected than average. This is the conclusion of the Whistleblowing 2025 report published today by the EQS Group and the Graubünden University of Applied Sciences (UAS).

Healthcare innovation

Pharma tariffs could trigger Swiss recession, warns economist

This content was published on Sep 30, 2025 US tariffs on pharmaceutical products could lead to a recession in Switzerland but there remains a lot of uncertainty.